The health ministry is making final arrangements to file a criminal complaint with prosecutors against Novartis Pharma K.K. over alleged exaggerated advertising for a blood pressure-lowering drug in violation of the pharmaceutical affairs law, ministry officials said Wednesday. The Health, Labor and Welfare Ministry initially planned to file the complaint with the Tokyo District Public Prosecutor’s Office on Wednesday, but delayed the move to make further preliminary arrangements with the prosecutors, the officials said. Clinical studies by two Japanese universities that concluded the blood pressure drug Diovan reduced the risk of cerebral stroke and angina were found to contain false data.
Help employers find you! Check out all the jobs and post your resume.
